Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 3
1991 1
1993 1
1994 3
1995 1
1996 3
1999 1
2001 1
2002 1
2004 3
2005 1
2008 2
2010 4
2011 3
2012 6
2013 4
2014 3
2015 3
2016 1
2017 1
2018 1
2019 1
2020 3
2021 6
2022 6
2023 9
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Macular Hole Closure with Medical Treatment.
Sokol JT, Schechet SA, Komati R, Eliott D, Vavvas DG, Kaplan RI, Ittiara ST, Farooq AV, Sheth VS, MacCumber MW, Ke R, Gentile RC, Skondra D. Sokol JT, et al. Among authors: maccumber mw. Ophthalmol Retina. 2021 Jul;5(7):711-713. doi: 10.1016/j.oret.2020.11.018. Epub 2020 Dec 16. Ophthalmol Retina. 2021. PMID: 33338669 Review. No abstract available.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.
Jhaveri CD, Liu D, Maguire MG, Glassman AR, Grigorian RA, Jampol LM, Kingsley RM, MacCumber MW, Martin DF, Maturi RK, Velez G, Sun JK; DRCR Retina Network. Jhaveri CD, et al. Among authors: maccumber mw. Ophthalmology. 2024 Aug;131(8):967-974. doi: 10.1016/j.ophtha.2024.01.037. Epub 2024 Feb 8. Ophthalmology. 2024. PMID: 38336282 Clinical Trial.
Progress in the treatment of posterior segment trauma.
MacCumber MW, de Juan E Jr. MacCumber MW, et al. Curr Opin Ophthalmol. 1994 Jun;5(3):44-9. doi: 10.1097/00055735-199406000-00008. Curr Opin Ophthalmol. 1994. PMID: 10172094 Review.
74 results